Dr. Emily Stein, MD
Claim this profileClinical Trials Emily Stein, MD is currently running
More about Emily Stein, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Emily Stein, MD has experience with
- Abaloparatide
- Placebo
- Spinal Fusion Surgery
Breakdown of trials Emily Stein, MD has run
Chronic Persistent Surgical Pain
Spinal Fusion
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emily Stein, MD specialize in?
Emily Stein, MD focuses on Chronic Persistent Surgical Pain and Spinal Fusion. In particular, much of their work with Chronic Persistent Surgical Pain has involved treating patients, or patients who are undergoing treatment.
Is Emily Stein, MD currently recruiting for clinical trials?
Yes, Emily Stein, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Emily Stein, MD has studied deeply?
Yes, Emily Stein, MD has studied treatments such as Abaloparatide, Placebo, Spinal Fusion Surgery.
What is the best way to schedule an appointment with Emily Stein, MD?
Apply for one of the trials that Emily Stein, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.